Advertisement
Singapore markets closed

  • Straits Times Index

    3,292.93
    -3.96 (-0.12%)
     

  • Nikkei

    38,236.07
    -37.98 (-0.10%)
     

  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • Bitcoin USD

    63,074.66
    +3,466.52 (+5.82%)
     

  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • Dow

    38,675.68
    +450.02 (+1.18%)
     

  • Nasdaq

    16,156.33
    +315.37 (+1.99%)
     

  • Gold

    2,310.10
    +0.50 (+0.02%)
     

  • Crude Oil

    77.99
    -0.96 (-1.22%)
     

  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     

  • FTSE Bursa Malaysia

    1,589.59
    +9.29 (+0.59%)
     

  • Jakarta Composite Index

    7,134.72
    +17.30 (+0.24%)
     

  • PSE Index

    6,615.55
    -31.00 (-0.47%)
     

Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)

GuruFocus Research
·1-min read

Director Gregory Bailey has recently increased his stake in Biohaven Ltd (NYSE:BHVN) by purchasing 48,780 shares of the company's stock, according to a SEC Filing dated 2024-04-22. This transaction has expanded Bailey's holdings in the company, contributing to a year-long pattern of insider purchases.Biohaven Ltd is a biopharmaceutical company engaged in the development and commercialization of innovative, late-stage drug candidates targeting neurological diseases, including rare disorders. The company's strategic approach focuses on providing new therapeutic options to patients with unmet medical needs.Insider transactions can provide insights into a company's financial health and management's confidence in the business. Over the past year, Gregory Bailey has acquired a total of 66,597 shares and has not sold any shares. This pattern of insider buying may signal confidence in the company's future prospects.The insider transaction history for Biohaven Ltd shows a trend of more insider buying than selling over the past year, with 9 insider buys and only 1 insider sell recorded.On the day of the insider's latest purchase, shares of Biohaven Ltd were trading at $41, valuing the company at a market cap of $3.232 billion.

Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)
Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)

The recent insider buying activity, as well as the overall trend observed over the past year, may be of interest to current and potential investors as they evaluate the company's stock performance and insider sentiment.

ADVERTISEMENT

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.